Anesiva
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Anesiva sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Anesiva: 7 sponsored US clinical trials, none currently recruiting.
Anesiva sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. 3 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Total Knee Arthroplasty (Replacement), with 1 trials.
Upper-quartile sponsor footprint
Anesiva sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
7 total, page 1 of 1
Efficacy and Safety Study of 4975 to Manage Pain of Bunionectomy
NCT00656578
Safety and Efficacy Study of 4975 in Patients Undergoing Total Knee Replacement
NCT00681356
Efficacy and Safety Study of 4975 in Patients Undergoing Total Hip Replacement
NCT00683267
Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis
NCT00125333
Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring Hemodialysis
NCT00086164
Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures
NCT00042081
Prevention of Autogenous Vein Graft Failure in Peripheral Artery Bypass Procedures
NCT00041925
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
| Phase 3 | 3 |
Therapeutic Areas
How the Anesiva archive is shaped
7 indexed studies, none listed as recruiting (0% open); 5 completed (71%).
Phase mix: 3 late (III/IV) vs 4 early (I/II) (balanced across stages).
Top condition: Total Knee Arthroplasty (Replacement) (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Anesiva: archived-pipeline peers nationwide
Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Anesiva sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 archived trials
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Anesiva page
7 registered trials is a research-attention snapshot, not an endorsement of Anesiva or any single study.
- None of Anesiva's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Total Knee Arthroplasty (Replacement) is the condition Anesiva studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Total Knee Arthroplasty (Replacement) trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Anesiva pipeline card: 7 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.